Development of Digital Biomarkers of Mental Illness via Mobile Apps for Personalized Treatment and Diagnosis

J Pers Med. 2022 Jun 6;12(6):936. doi: 10.3390/jpm12060936.

Abstract

The development of precision psychiatry is largely based on multi-module measurements from the molecular, cellular, and behavioral levels, which are integrated to assess neurocognitive performances and clinically observed psychopathology. Nevertheless, quantifying mental activities and functions accurately and continuously has been a major difficulty within this field. This article reviews the latest efforts that utilize mobile apps to collect human-smartphone interaction data and contribute towards digital biomarkers of mental illnesses. The fundamental principles underlying a behavioral analysis with mobile apps were introduced, such as ways to monitor smartphone use under different circumstances and construct long-term patterns and trend changes. Examples were also provided to illustrate the potential applications of mobile apps that gain further insights into traditional research topics in occupational health and sleep medicine. We suggest that, with an optimized study design and analytical approach that accounts for technical challenges and ethical considerations, mobile apps will enhance the systemic understanding of mental illnesses.

Keywords: digital biomarkers; digital footprint; digital phenotyping; e-mental health; mobile applications.

Publication types

  • Review

Grants and funding

This research was funded by the National Health Research Institutes, Taiwan (NHRI-EX111-11025PI) and the Ministry of Science and Technology, Taiwan (MOST 110-2314-B-400-054). The APC was funded by the Ministry of Science and Technology, Taiwan (MOST 110-2314-B-400-054).